SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-8.23 Cr | ₹-22 Cr | ₹-10 Cr | ₹150 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUPRIYA LIFESCIENCE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-8.23 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹150 Cr |
| Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of SUPRIYA LIFESCIENCE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.23 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹150 Cr | Positive | |
| Mar2021 | ₹-15 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,800.6 Cr | 0.4% | -11.9% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 0.4% |
-11.9% |
15.4% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses